Track topics on Twitter Track topics that are important to you
Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 10:00 a.m. ET on Tuesday, October 31, 2017.
The schedule for the press release and conference call/webcast is as follows:
• Q3 2017 Press Release:
|October 31, 2017 at 7:00 a.m. ET|
• Q3 2017 Conference Call:
|October 31, 2017 at 10:00 a.m. ET|
• Domestic Dial-In Number:
• International Dial-In Number:
• Conference ID Number:
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13672268.
The live webcast with slides can be accessed at www.incyte.com under For Investors, Events and Presentations and will be available for replay for 30 days.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's website at www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...